share_log

UPLOAD: Others

UPLOAD: Others

UPLOAD:其他
美股sec公告 ·  04/16 13:23
Moomoo AI 已提取核心信息
On April 15, 2024, the United States Securities and Exchange Commission (SEC) addressed a letter to Sanjeev Redkar, President of Apollomics Inc., regarding the company's Registration Statement on Form F-3. The SEC reviewed Apollomics' response dated April 12, 2024, and requested further amendments to the registration statement, along with additional information. The SEC's inquiry specifically pointed out an inconsistency between the company's claim that all board members reside outside of China and the disclosure that two directors are based in mainland China. The SEC indicated that after reviewing Apollomics' forthcoming amendment and response, additional comments may follow. The SEC provided contact information for further questions, directing them to Daniel Crawford and Tim Buchmiller from the Division of Corporation Finance Office of Life Sciences.
On April 15, 2024, the United States Securities and Exchange Commission (SEC) addressed a letter to Sanjeev Redkar, President of Apollomics Inc., regarding the company's Registration Statement on Form F-3. The SEC reviewed Apollomics' response dated April 12, 2024, and requested further amendments to the registration statement, along with additional information. The SEC's inquiry specifically pointed out an inconsistency between the company's claim that all board members reside outside of China and the disclosure that two directors are based in mainland China. The SEC indicated that after reviewing Apollomics' forthcoming amendment and response, additional comments may follow. The SEC provided contact information for further questions, directing them to Daniel Crawford and Tim Buchmiller from the Division of Corporation Finance Office of Life Sciences.
2024年4月15日,美国证券交易委员会(SEC)就该公司在F-3表格上的注册声明致函Apollomics Inc. 总裁桑杰夫·雷德卡。美国证券交易委员会审查了Apollomics于2024年4月12日作出的回应,并要求对注册声明进行进一步修改,并提供更多信息。美国证券交易委员会的调查特别指出,该公司声称所有董事会成员都居住在中国境外,但披露有两名董事居住在中国大陆,这两者之间存在不一致之处。美国证券交易委员会表示,在审查了Apollomics即将发布的修正案和回应后,可能会发表更多评论。美国证券交易委员会为进一步的问题提供了联系信息,将他们引向了生命科学公司财务部生命科学办公室的丹尼尔·克劳福德和蒂姆·布赫米勒。
2024年4月15日,美国证券交易委员会(SEC)就该公司在F-3表格上的注册声明致函Apollomics Inc. 总裁桑杰夫·雷德卡。美国证券交易委员会审查了Apollomics于2024年4月12日作出的回应,并要求对注册声明进行进一步修改,并提供更多信息。美国证券交易委员会的调查特别指出,该公司声称所有董事会成员都居住在中国境外,但披露有两名董事居住在中国大陆,这两者之间存在不一致之处。美国证券交易委员会表示,在审查了Apollomics即将发布的修正案和回应后,可能会发表更多评论。美国证券交易委员会为进一步的问题提供了联系信息,将他们引向了生命科学公司财务部生命科学办公室的丹尼尔·克劳福德和蒂姆·布赫米勒。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息